These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6209498)

  • 1. Effects of acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on cardiodynamics and myocardial metabolism in dogs.
    Seitelberger R; Kraupp O; Beck A; Bacher S; Raberger G
    J Cardiovasc Pharmacol; 1984; 6(5):902-8. PubMed ID: 6209498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acylcarnitine transferase blockade on metabolism and function in the normally and underperfused canine myocardium.
    Seitelberger R; Huber S; Schwarzacher S; Raberger G
    J Clin Chem Clin Biochem; 1990 May; 28(5):341-6. PubMed ID: 2380672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium.
    Seitelberger R; Kraupp O; Winkler M; Brugger G; Raberger G
    J Cardiovasc Pharmacol; 1985; 7(2):273-80. PubMed ID: 2581080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.
    Rösen P; Reinauer H
    Metabolism; 1984 Feb; 33(2):177-85. PubMed ID: 6694560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
    Rösen P; Reinauer H
    Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of POCA on metabolism and function in the ischemic rat heart.
    Paulson DJ; Noonan JJ; Ward KM; Stanley H; Sherratt A; Shug AL
    Basic Res Cardiol; 1986; 81(2):180-7. PubMed ID: 3741356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acylcarnitine-transferase inhibitors on adenine nucleotide metabolism and ischemic tissue injury in isolated perfused rat heart.
    Shikama H; Noshiro O; Ohta A; Ohata I
    Jpn Heart J; 1988 Sep; 29(5):723-34. PubMed ID: 3221447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on carbohydrate and fatty acid metabolism in liver and muscle.
    Schudt C; Simon A
    Biochem Pharmacol; 1984 Nov; 33(21):3357-62. PubMed ID: 6437406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
    Turnbull DM; Bartlett K; Younan SI; Sherratt HS
    Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
    Lopaschuk GD; Wall SR; Olley PM; Davies NJ
    Circ Res; 1988 Dec; 63(6):1036-43. PubMed ID: 3197271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
    Vaartjes WJ; De Haas CG; Haagsman HP
    Biochem Pharmacol; 1986 Dec; 35(23):4267-72. PubMed ID: 3790153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
    Koundakjian PP; Turnbull DM; Bone AJ; Rogers MP; Younan SI; Sherratt HS
    Biochem Pharmacol; 1984 Feb; 33(3):465-73. PubMed ID: 6231030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
    Reinauer H; Adrian M; Rösen P; Schmitz FJ
    J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial metabolism during pentobarbital anesthesia in dogs.
    Durham BC; Miller HI
    Anesthesiology; 1975 Apr; 42(4):464-70. PubMed ID: 1119713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
    Corr PB; Creer MH; Yamada KA; Saffitz JE; Sobel BE
    J Clin Invest; 1989 Mar; 83(3):927-36. PubMed ID: 2921326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L; Pillay D; Alberti KG; Sherratt HS
    Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid accumulation during ischemia and reperfusion: effects of pyruvate and POCA, a carnitine palmitoyltransferase I inhibitor.
    van Bilsen M; van der Vusse GJ; Willemsen PH; Coumans WA; Reneman RS
    J Mol Cell Cardiol; 1991 Dec; 23(12):1437-47. PubMed ID: 1811059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive evaluation of fat-carbohydrate metabolic switching in heart and contracting skeletal muscle.
    DeGrado TR; Pandey MK; Belanger AP; Basuli F; Bansal A; Wang S
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E251-E259. PubMed ID: 30512988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new experimental model for studies of drug actions on myocardial metabolism. Application to a study of the influence of POCA.
    Bontemps L; Demaison L; Dubois F; Pernin C; Mathieu JP; Vidal M; Comet M; Cuchet P
    Int J Rad Appl Instrum B; 1987; 14(5):459-65. PubMed ID: 3667310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.